In conclusion, the CDK5-NGF/Sirt1 regulating axis may be the novel pathway to prevent DN progression and TFP5 may be a promising compound to improved hyperglycemia induced DN. The gene discussed is SIRT1; the disease is liver dysplastic nodule.